Log In
Print this Print this

SINE CRM1 antagonist

  Manage Alerts
Collapse Summary General Information
Company Karyopharm Therapeutics Inc.
DescriptionOral selective inhibitor of nuclear export (SINE) protein exportin 1 (XPO1; CRM1) antagonist
Molecular Target Exportin 1 (XPO1) (CRM1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today